ArticleMolecular cancer therapeutics2022

Preclinical Evaluation of 225Ac-Labeled Single-Domain Antibody for the Treatment of HER2pos Cancer.

Magdalena Rodak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.